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Abstract
Alternative (M2) macrophage activation driven through interleukin 4 receptor α (IL-4Rα) is 
important for immunity to parasites, wound healing, the prevention of atherosclerosis and 
metabolic homeostasis. M2 polarization is dependent on fatty acid oxidation (FAO), but the source 
of fatty acids to support this metabolic program has not been clear. We show that the uptake of 
triacylglycerol substrates via CD36 and their subsequent lipolysis by lysosomal acid lipase (LAL) 
was important for the engagement of elevated oxidative phosphorylation (OXPHOS), enhanced 
spare respiratory capacity (SRC), prolonged survival and expression of genes that together define 
M2 activation. Inhibition of lipolysis suppressed M2 activation during infection with a parasitic 
helminth, and blocked protective responses against this pathogen. Our findings delineate a critical 
role for cell-intrinsic lysosomal lipolysis in M2 activation.
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Macrophages exist throughout the body as resident components of most tissues. They are 
embryonically derived, seeded into tissues in utero, and maintained by in situ 
proliferation1,2. During inflammation additional macrophages develop from monocytes 
recruited from the bone marrow1, or from proliferation of resident cells3. Macrophages are 
crucial for immunity and can adopt different activation states depending on context. 
Interferon-γ(IFN-γ in combination with Toll-like receptor (TLR) agonists promotes M1 (or 
classical) activation, whereas the cytokines interleukin 4 (IL-4) and IL-13 promote M2 (or 
alternative) activation4,5. From the host defense standpoint, M1 macrophages are 
inflammatory and can play a positive role in immunity to microbial pathogens and tumors5. 
In contrast, M2 macrophages promote tissue repair and metabolic homeostasis, and play key 
roles in immunity to parasitic helminths5.
M1 and M2 macrophages have distinct metabolic phenotypes, which differ from those of 
resting macrophages6,7. M1 macrophages rely on aerobic glycolysis, while M2 macrophages 
use fatty acid oxidation (FAO, also known as β-oxidation) to fuel mitochondrial oxidative 
phosphorylation (OXPHOS). IL-4-induced changes in macrophage metabolism are 
dependent upon the transcription factor STAT6 and underpinned by the induction of 
expression of PPARγ-coactivator-1β (PGC1β) and associated mitochondrial biogenesis8. M2 
activation is prevented by inhibition of FAO, whereas overexpression of PGC1β is sufficient 
to attenuate M1 activation in response to IFN-γ and lipopolysaccharide (LPS)8. Thus IL-4-
induced FAO is critical for M2 activation. In other immune cells FAO is known to support 
cellular longevity9,10, but whether or not this is the case in macrophages is unclear.
Because of the health implications of M2 macrophage activation in various settings, there is 
considerable interest in understanding the cellular pathways that underpin the M2 
phenotype. Despite the established importance of FAO for M2 activation, the source of fatty 
acids to support this process is unknown. The consensus view from work in other cell types 
is that fatty acids to meet metabolic and other requirements are released through a 
coordinated process of lipolysis from triacylglycerols stored in lipid droplets (LDs) that is 
initiated by the enzyme adipose triglyceride lipase (ATGL)11,12. However, the expression of 
CD36, which is a receptor for the endocytosis of triacylglycerol-rich lipoprotein particles, 
such as LDL and VLDL13,14, is induced in macrophages by IL-4 (ref. 15), and has been 
implicated in M2 activation16. Those findings suggested to us that the uptake and lipolysis 
of exogenous triacylglycerols may serve to generate fatty acids for FAO in M2 
macrophages. Consistent with this view, we report here that lysosomal lipolysis mediated by 
lysosomal acid lipase (LAL), an enzyme that is expressed in macrophages as they 
differentiate from monocytes17, and which is further induced by stimulation with IL-4, plays 
an important role in M2 activation. Inhibition of this pathway suppressed changes in 
OXPHOS and macrophage longevity and the expression of key genes that mark M2 
commitment. Many of the effects of lipolysis inhibition were recapitulated in CD36-
deficient macrophages. Our data highlight a previously unappreciated role for LAL in 
macrophage cell-intrinsic lipolysis to support FAO, show that this enzyme is integral to the 
M2 activation pathway, and provide a framework for understanding the contribution of 
CD36 to these processes.
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Results
M2 macrophage activation is dependent on fatty acid oxidation
Using extracellular flux analysis, we compared oxygen consumption by M0 (unactivated), 
M1 and M2 bone marrow-derived macrophages. We found that M2 macrophages had 
enhanced mitochondrial oxygen consumption rates (OCR), and markedly increased spare 
respiratory capacity (SRC10,18 the quantitative difference between maximal uncontrolled 
OCR, and the initial basal OCR), indicative of increased commitment to OXPHOS (Fig. 1a). 
In contrast, we found no evidence of mitochondrial oxygen consumption in M1 
macrophages (Fig. 1a), which rather rely on aerobic glycolysis, measured as the 
extracellular acidification rate, ECAR (Fig. 1b), to meet their bioenergetic needs19. The 
extent of the metabolic difference between M1 and M2 cells was apparent in the overall 
ratio of OXPHOS to aerobic glycolysis, which was 10-fold higher in M2 than M1 
macrophages, reflecting polar opposite core metabolic programs (Fig. 1c). Consistent with 
previous reports, we found that commitment of M2 macrophages to FAO and OXPHOS was 
evident in the increased expression of genes in these pathways (Supplementary Fig. 
1a,c)8,20. This pathway was also sensitive to the suppression of mitochondrial oxygen 
consumption by etomoxir, an inhibitor of Cpt1, a key FAO enzyme (Fig. 1d)8. We found 
that etomoxir also eradicated SRC in M2 macrophages (Fig. 1e), validating the link between 
FAO and heightened OXPHOS. Enhanced SRC was previously linked to longevity in 
memory CD8+ T cells10. We found this increased longevity to also be true in macrophages, 
where M2 cells exhibited a significant survival advantage compared to M0 and M1 cells in 
culture (Supplementary Fig. 2).
M2 and M1 macrophage activation are marked by the differential expression of a large panel 
of genes, including Mrc1 (CD206), Clec10a (CD301), Retlna (RELMα), Pdcd1lg2
(PD-L2) and Nos2 (iNOS) (Supplementary Fig. 1b,c). Using flow cytometry, we found 
that etomoxir remarkedly inhibited the expression of CD301, CD206 and RELMα in 
macrophages cultured in M2 conditions (Fig. 1f,g), but had comparatively little effect on the 
expression of iNOS in cells cultured in M1 conditions (Fig. 1h). Thus, FAO, measureable as 
increased baseline OCR and increased SRC, is essential for M2 activation.
Lipolysis contributes to M2 activation
Cellular requirements for fatty acids can be met by enzymatically regulated lipolysis of 
triacylglycerols into diacylglycerols and monoacylglycerols, accompanied by fatty acid 
release11; an endpoint of this process is the release of glycerol from cells in which lipolysis 
is occurring11. We performed global metabolite profiling using mass spectrometry and 
found significantly increased amounts of 3 out of 4 monoacylglycerols measured in M2 
cells, indicating that lipolysis is enhanced in these cells (Fig. 2a). Consistent with this 
conclusion, we found increased concentrations of extracellular glycerol were present in 
cultures of M2 compared with M0 macrophages (Fig. 2b). To test whether lipolysis is linked 
to FAO and OXPHOS, we stimulated cells with IL-4 in the presence or absence of 
tetrahydrolipistatin (Orlistat), a clinically utilized active site-directed lipase inhibitor21. We 
found that Orlistat inhibited IL-4-induced increases in lipolysis, as measured by glycerol 
Huang et al. Page 3
Nat Immunol. Author manuscript; available in PMC 2015 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
production (Fig. 2b), and suppressed associated changes in OXPHOS (Fig. 2c), although it 
had no effect on the metabolic changes induced by M1 conditions (Fig. 2d). These 
reductions in OXPHOS and SRC in Orlistat-treated M2 cells were linked to significantly 
reduced survival, evident as in decreased viability by day 2 of culture (Fig. 2e). Orlistat had 
less marked effects on the survival of M0 cells (Fig. 2e). Within the short timeframe that M1 
cells remained alive, we could detect no significant effect of inhibiting lipolysis on their 
survival (data not shown). Given the close link between FAO and M2 activation, we next 
tested the effects of inhibiting lipolysis on macrophages stimulated with IL-4. We found that 
Orlistat suppressed the IL-4 induced expression of CD206, CD301, PD-L2 and 
RELMα(Fig. 2f), but had no effect on iNOS expression in M1 macrophages (Fig. 2g). 
Together, these data indicate that lipolysis supports FAO and in this way is critical for M2 
activation.
Lysosomal acid lipase is responsible for lipolysis upstream of FAO
Our data implicated lipolysis as a critical mechanism for the generation of fatty acids for 
FAO and M2 activation in macrophages stimulated with IL-4. In other cells fatty acids for 
FAO are released from triacylglycerols stored with cholesterol esters in LDs by a process of 
lipolysis initiated by ATGL and continued by hormone-sensitive lipase (HSL), encoded by 
Pnpla2 and Lipe, respectively11,12,22. However, amongst genes encoding lipases, we found 
that Pnpla2 and Lipe were expressed more strongly in M1 cells than in M2 cells (Fig. 3a), 
suggesting that these genes might not play a role in M2 activation. To directly test this, we 
measured RELMα expression in peritoneal macrophages (PM) from Pnpla2–/– mice 
following the i.p. injection of IL-4–anti-IL-4 complexes (IL-4c), a procedure shown 
previously to induce peritoneal macrophage M2 activation23. We found that >90% of 
macrophages in Pnpla2–/– mice or in wild-type mice expressed RELMα following IL-4c 
injection, indicating that the loss of ATGL has no effect on M2 activation (Supplementary 
Fig. 3a). A substantial body of literature has associated M1 activation with the development 
of lipid droplets24, but whether or not lipid droplets are prevalent in M2 macrophages is 
unclear. Using transmission electron microscopy (TEM) we found that M1 macrophages 
contained easily identifiable lipid droplets, whereas M2 cells did not (Fig. 3b). Together 
with the lipase expression data and data from experiments using Pnpla2–/– macrophages, 
these findings suggest that M2 macrophages are not utilizing canonical lipid droplet-
triacylglycerol hydrolysis pathways to generate fatty acids for FAO. Nevertheless, we did 
observe that neutral lipids as measured by flow cytometric detection of BODIPY stainin, the 
appearance of lipid droplets as visualized by electron microscopy, and the quantitation of 
triacylglycerols and cholesterol esters by mass spectrometry, accumulated in macrophages 
stimulated with IL-4 in the presence of Orlistat (Supplementary Fig. 3b-d). Mass 
spectrometry additionally confirmed that neutral lipid stores are greater in M1 macrophages 
than in M2 macrophages (Supplementary Fig. 3d). These findings indicate that M2 
macrophages accumulate neutral lipid stores when lipolysis is inhibited.
We noted that, unlike genes encoding many other cellular lipases (including Pnpla2, Lipe, 
Lipc, Lipg), expression of Lipa was upregulated in M2 compared to M1 macrophages (Fig. 
3a, Supplementary Fig. 1c), suggesting that it could be important for M2 activation. Lipa 
encodes LAL, a triacylglycerol lipase that is able to breakdown triacylglycerols delivered 
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into the lysosomes by endocytosis of low density lipoproteins (LDLs and VLDLs)25. Since 
LAL is a known target of Orlistat26, we reasoned that the observed effects of Orlistat on 
macrophage FAO and M2 activation (Fig. 2) could reflect the inhibition of LAL function in 
this system. To investigate the role of LAL, which unlike the other cellular lipases has 
optimum activity at acidic rather than neutral pH, in M2 activation, we first neutralized 
lysosomal pH using chloroquine or Bafilomycin A1. We found that these conditions 
completely inhibited the IL-4–induced increases in OXPHOS, as measured by OCR, OCR/
ECAR ratio and SRC (Fig. 3c). These effects were accompanied by the inhibition of IL-4–
induced increases in CD206, CD301, PD-L2 and RELMα expression (Fig. 3d) and a 
decrease in longevity (Fig. 3e). These data support the view that an acidic compartment is 
essential for M2 activation and are consistent with a role for LAL in this process. To 
formally address this possibility, we targeted LAL using shRNAs, and found that increased 
OXPHOS, expression of CD206, CD301, RELMα and PD-L2, and increased longevity in 
response to IL-4 were significantly inhibited by the suppression of LAL expression (Fig. 3f-
h). Suppression of LAL expression also resulted in the accumulation of lipid droplets in 
macrophages stimulated with IL-4 (Supplementary Fig. 3b). Additionally, we examined 
the ability of Lipa–/– macrophages to become M2 activated and found that increases in 
expression of CD206, CD301 and RELMα were significantly muted in Lipa–/– macrophages 
versus wild-type cells (Fig. 3i). Finally, we made bone marrow chimeras in which irradiated 
CD45.2 mice were reconstituted with CD45.1 bone marrow that had been bone transduced 
with retrovirus encoding shRNAs targeting Lipa or a control gene (luciferase). Progeny from 
transduced cells could be distinguished via expression of human CD8 encoded as a reporter 
by the retrovirus. We examined M2 activation of peritoneal macrophages derived from 
CD45.1+ transduced versus untransduced bone marrow cells following i.p. injection of 
IL-4c. We found that peritoneal macrophage RELMα expression in response to IL-4 was 
inhibited by the suppression of LAL expression (Fig. 3j). Together, these data indicate that 
cell-intrinsic lipolysis mediated by LAL plays a critical role in optimal macrophage M2 
activation in response to IL-4.
Elevated OXPHOS and optimal M2 activation are dependent on CD36
The important role for LAL in M2 macrophages suggested that triacylglycerol delivery to 
lysosomes is a key process in the generation of fatty acids to support FAO and M2 
activation. We examined the expression of receptors that mediate the uptake of 
triacylglycerol-carrying serum lipoproteins in M2 macrophages and observed that CD36 was 
upregulated in M2 cells (Fig. 4a)15. The same was true for the related scavenger receptor 
Scarb1, but not for Ldlr1, Vldlr, or Lrp8 (Fig. 4a, Supplementary Fig. 1c). Based on these 
observations, and the fact that CD36 has been previously implicated in M2 activation16, we 
hypothesized that CD36 may play a role in increased FAO in M2 macrophages by 
facilitating the uptake of triacylglycerols. To examine this, we assessed responses to IL-4 of 
macrophages made from the bone marrow of Cd36–/– mice. We found that compared to M0 
macrophages, wild-type M2 macrophages, but not Cd36–/– M2 macrophages, took up more 
LDL (Fig. 4b) and VLDL (Fig. 4c). In addition to being a receptor for LDL and VLDL, 
CD36 is a fatty acid translocase13,14. While we found M2 macrophages to be more capable 
than M0 cells of taking up palmitate, we observed no difference between wild-type and 
Cd36–/– cells in this regard (Supplementary Fig. 4a), suggesting that the fatty acid 
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translocase activity of CD36 is not accounting for increased free fatty acid uptake by M2 
cells. Compared to wild-type macrophages, Cd36–/– macrophages exhibited significantly 
lower IL-4 induced increases in OXPHOS as measured by OCR, the OCR/ECAR ratio and 
SRC (Fig. 4d), but were substantially similar in terms of the metabolic markers of M1 
activation (Fig. 4e). Consistent with the critical role for FAO in M2 activation, Cd36–/– 
macrophages exhibited substantially reduced levels of expression of PD-L2 and RELMαin 
response to IL-4 (Fig. 4f). In comparison, iNOS expression was similar in wild-type and 
Cd36–/– macrophages stimulated in M1 conditions (Fig. 4g). We further addressed the role 
of CD36 by examining the effect on wild-type macrophage responses to IL-4 of inhibiting 
CD36 with sulfo-N-succinimidyl oleate (SSO)27. The findings from these experiments 
confirmed those from using Cd36–/– macrophages. We found that LDL uptake was 
substantially inhibited by SSO (Supplementary Fig. 4b). Moreover, SSO completely 
blocked IL-4-induced increases in OXPHOS as measured by OCR, the OCR/ECAR ratio 
and SRC (Supplementary Fig. 4c) but had no effect on metabolic markers of M1 activation 
(Supplementary Fig. 4d). SSO substantially inhibited expression of CD206, CD301, PD-
L2 and RELMαin response to IL-4 (Supplementary Fig. 4e), but had no effect on iNOS 
expression in M1 macrophages (Supplementary Fig. 4f). Together, these data support the 
view that elevated CD36 expression in macrophages in response to IL-4 plays an important 
role in increased uptake of LDL and VLDL, and that this pathway supports FAO and M2 
activation.
Next we tested the ability of monocyte-derived macrophages from a CD36-deficient patient 
to become alternatively activated in response to IL-4. We found that SRC was substantially 
diminished in human CD36-deficient M2 macrophages compared to CD36-sufficient human 
M2 macrophages (Fig. 4h). Expression of CD206, the mannose receptor C type 1 (MRC1), 
is a marker of human M2 activation, as is expression of CD3628. Thus we used flow 
cytometry to examine CD36 and CD206 expression in M0, M1 and M2 macrophages from 
CD36-sufficient and -deficient subjects. We found that CD36 and CD206 expression were 
elevated in M2 versus M0 and M1 macrophages, and that expression of CD206 was 
substantially lower in CD36-deficient macrophages stimulated with IL-4 compared to 
CD36-sufficient macrophages (Fig. 4i). Together with our findings from mouse Cd36–/– 
macrophages and the SSO inhibitor studies, these data from human CD36-deficient 
macrophages strongly support a significant role for CD36 in M2 activation.
Our data suggested that the lysosomal lipolysis of exogenous triacylglycerols acquired 
through a CD36-dependent mechanism is important for optimal M2 activation. In this case, 
we reasoned that depriving macrophages of exogenous triacylglycerols should impact M2 
activation. We cultured macrophages in complete medium containing or lacking serum for 
24 h and then measured the expression of key M2 marker genes following an additional 24 h 
of stimulation with IL-4. In these experiments, M2 activation was substantially inhibited, but 
not prevented, by the absence of serum (Supplementary Fig. 5a). Consistent with our data 
implicating CD36-mediated uptake of LDL and VLDL in M2 macrophages, we found that 
under serum-free conditions, M2 activation could be promoted by the addition of LDL and 
VLDL (Supplementary Fig. 5a). The finding that M2 activation could proceed to some 
extent in the absence of serum, suggested that macrophages have an alternative pathway to 
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fuel FAO. A candidate for such an alternative pathway is fatty acid synthesis. To explore 
this possibility, we examined how M2 activation was affected by (5-(Tetradecyloxy)-2-
furoic Acid (TOFA), an inhibitor of acetyl-CoA carboxylase, which catalyzes an early step 
in the synthesis of fatty acid from acetyl-CoA. TOFA completely blocked M2 activation in 
serum-free conditions and, in the presence of serum, reduced activation to levels observed in 
inhibitor-free, serum-free conditions (Supplementary Fig. 5b). These data suggest that 
macrophages possess an underlying pathway through which, in the presence of IL-4, they 
synthesize fatty acids to support M2 activation, and that optimal M2 activation requires 
contributions of exogenous triacylglycerols and de novo synthesized fatty acids.
These findings raised the question of whether M2 macrophages first incorporate 
endogenously synthesized fatty acids into triacylglycerols prior to liberating them by 
lipolysis for FAO, as has been suggested to be the dominant pathway in other cell types11. 
We examined this by first testing the effect of Orlistat on M2 activation in serum-free 
conditions. We found that the inhibition of lipolysis under these conditions did inhibit M2 
activation (Supplementary Fig. 5b), indicating that endogenously synthesized fatty acids 
are incorporated into triacylglycerols in M2 macrophages. Triacylglycerols synthesized in 
this way are stored as lipid droplets, but our ultrastructural analysis failed to identify lipid 
droplets in M2 cells (Fig. 3b). However, we did observe lipid droplets in macrophages 
stimulated with IL-4 in the presence of Orlistat and in macrophages transduced with shRNA 
targeting Lipa (Supplementary Fig. 3b). Since the inhibition of lipolysis precludes the 
synthesis of these neutral lipid stores from fatty acids liberated from acquired 
triacylglycerols, we assume that they are produced from de novo synthesized fatty acids. 
Taken together, our data raise the possibility that in addition to a primary pathway in which 
exogenous triacylglycerols are broken down in the lysosomal compartment to support FAO, 
M2 macrophages are also able to synthesize triacylglycerols from de novo synthesized fatty 
acids and hydrolyze these via the same pathway.
M2 activation during helminth infection is LAL-dependent
Our data indicated that lipolysis is essential for the metabolic switch and associated changes 
in the expression of key genes that occur as macrophages become alternatively activated in 
response to IL-4. To assess whether lipolysis is critical for M2 activation in vivo, we used 
the Heligmosomoides polygyrus bakeri (H. polygyrus) mouse model of human intestinal 
helminth infection, in which M2 macrophages play an essential role in immunity29. We 
found that peritoneal macrophage numbers increased significantly over time during this 
infection (Fig. 5a), and that peritoneal macrophages from infected mice exhibited the 
metabolic profile of IL-4-activated bone marrow macrophages, with heightened baseline 
OCR and marked SRC (Fig. 5b). Consistent with previous observations, a substantial 
percentage of peritoneal macrophages from H. polygyrus-infected mice expressed the M2 
marker RELMα (Fig. 5c)30. We found that maintenance of the peritoneal M2 macrophage 
activation phenotype is LAL-dependent in this setting since increases in OCR and RELMα 
expression were significantly inhibited when peritoneal macrophages were treated ex-vivo 
with siRNAs targeting Lipa (Fig. 5d,e). The dependence of M2 activation on LAL was also 
apparent when peritoneal cells were maintained in a type 2 environment through the addition 
of IL-4 in vitro (Fig. 5f,g). These data indicate that macrophages in a type 2 cytokine 
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environment in vivo exhibit lipolysis-dependent changes in metabolism and M2 marker gene 
expression that are equivalent to those induced by IL-4 in bone marrow derived 
macrophages in vitro.
Inhibition of lipolysis suppresses parasite elimination
Primary infection with H. polygyrus in B6 mice is chronic despite the development of a type 
2 cytokine response. However, injection of IL-4c into infected mice results in reductions in 
adult parasite numbers, and M2 macrophages are implicated in the protective mechanism 
induced by this cytokine3,29,31. Given our findings, we reasoned that lipolysis should be 
crucial for the development of M2 macrophages in these settings, and therefore that 
inhibition of this pathway would limit the expression of M2 macrophage-dependent 
protective immune responses. We found that IL-4c injected after primary infection markedly 
enhanced peritoneal macrophage OXPHOS (Fig. 6a) and increased RELMα expression 
(Fig. 6b), while simultaneously significantly reducing parasite burden, as measured by egg 
and adult worm counts (Fig. 6c,d). Consistent with a major role for lipolysis in M2 
polarization, we found that enhanced M2 activation and concomitant protective effects 
associated with IL-4c injection were significantly inhibited by parenteral Orlistat treatment 
(Fig. 6a-e).
Mice in which primary H. polygyrus is cleared by chemotherapy exhibit a degree of 
immunity to secondary infection29. We compared the peritoneal macrophage response 
during primary H. polygyrus infection to that of a secondary re-infection following parasite 
clearance by administration of pyrantel pamoate and resting the animals for five weeks. We 
found that peritoneal macrophage numbers (Fig. 7a) and the magnitude of the increase in 
OXPHOS and RELMαexpression (Fig. 7b,c) were all significantly greater in mice 
responding to secondary infection. This correlated with resistance to secondary infection, 
apparent as a >50% drop in adult worm burdens arising from secondary vs. primary 
infections (Fig. 7d). We then asked whether inhibition of lipolysis following secondary 
infection affected enhanced M2 activation, or resistance to secondary infection. We found 
that Orlistat treatment prevented the increase in peritoneal macrophage numbers that 
occurred during secondary infection (Fig. 7a), inhibited all measured parameters of 
enhanced M2 activation (Fig. 7b,c) and suppressed resistance to reinfection in immune mice 
(Fig. 7d).
Given the experimental approach used here, there was a possibility that Orlistat was 
affecting not only macrophage function, but also adaptive immunity. To address this, we 
used 4get/KN2 IL-4 reporter mice to enumerate CD4+ type 2 helper T cells (TH2) cells in 
mesenteric lymph nodes following primary or secondary infections with or without Orlistat 
treatment. We found that inhibition of lipolysis during the development of the effector or 
secondary effector response had no measurable effect on the adaptive response, as measured 
by the overall cellularity of the MLN (Supplementary Fig. 6a), or the numbers of IL-4–
secreting TH2 cells in the MLN (Supplementary Fig. 6b). Furthermore, examining IL-4 
reporter expression in all live cells from mice treated with Orlistat failed to reveal any 
effects on non-TH2 sources of IL-4 (data not shown). In summary, our data show that the 
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inhibition of lipolysis is able to block macrophage M2 activation associated with resistance 
to the helminth parasite H. polygyrus, and in so doing suppress immunity to this pathogen
Discussion
We have found that accentuated FAO and related SRC in macrophages stimulated with IL-4 
are dependent on a pathway of cell-intrinsic lipolysis mediated by the lysosomal enzyme 
LAL. Consistent with the necessity to generate fatty acids to fuel FAO and the importance 
of FAO for M2 activation, we found that LAL is expressed to a greater extent in M2 than in 
M1 macrophages, and is critical for full macrophage M2 activation in response to IL-4.
Mutations in LAL cause Wolman's disease and cholesterol ester storage disease (CESD), 
which are characterized by varying degrees of accumulation of triacylglycerols and 
cholesterol esters in the liver, intestine and adrenal glands, but also in blood vessels and 
spleen. Notably, triacylglycerol accumulation in macrophages is associated with deficiencies 
in LAL activity, and atherosclerosis, a disease ameliorated by M2 activation32,33 develops 
prematurely in CESD (discussed in 25). Moreover, genome-wide association studies 
(GWAS) have revealed that polymorphisms in Lipa are associated with premature human 
coronary artery disease at least 3 distinct genetic backgrounds34, 35. Thus a genetic link 
exists between LAL and a disease in which M2 macrophages are considered to play an 
important protective role. The clinical evidence provides support for the possibility that LAL 
plays an important role in M2 macrophage biology. Lipa–/– mice provide a model for human 
LAL deficiencies, and have provided insight into the role played by LAL in the immune 
system. In these mice, which die prematurely, lymphopoiesis is reduced and accompanied 
by a myeloproliferative disorder and multi-organ sterile inflammation36, which can be 
reversed by the macrophage-specific expression of human LAL37, supporting the view that 
macrophage LAL plays a critical role in the homeostatic control of inflammation. Those 
data are consistent with our finding that LAL is essential for M2 activation and the known 
ability of M2 activation to ameliorate inflammation in many settings. Interestingly, bone 
marrow transplantation has been used to treat Wolman's disease38, supporting the view that 
lack of LAL expression in cells of hematopoietic origin is critical for the pathogenesis of 
this disease.
It has been suggested previously that compared to M1 macrophages, which exert their 
functions over short time periods, M2 macrophages are engaged in activities which are more 
prolonged, and that the relative efficiency of FAO versus glycolysis is well suited to meet 
the metabolic requirements of these roles7. Consistent with this view we found that M2 
macrophages survive longer than M1 macrophages in culture and possess marked SRC, a 
characteristic which in CD8+ T lymphocytes is linked to the enhanced FAO and cellular 
longevity of memory cells10. In parallel studies LAL was also shown to be responsible for 
the generation of fatty acids for FAO in memory CD8+ T cells, a process that is driven by 
IL-1539, suggesting that LAL has broadly assumed the role of coordinating cytokine (IL-4 or 
IL-15)-induced increases in FAO to support longevity in immune cells. Interestingly, the 
expansion of M2 peritoneal macrophages that occurs in immune mice following challenge 
infection with H. polygyrus did not occur when lipolysis was inhibited. This finding may 
reflect reduced survival of these cells due to reduced FAO, as was apparent in tissue-
Huang et al. Page 9
Nat Immunol. Author manuscript; available in PMC 2015 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
cultured Orlistat-treated M2 macrophages. An alternative explanation is that this failure is 
the result of reduced proliferation within the M2 macrophage population. Recent reports 
have indicated that helminth infection-induced M2 macrophages proliferate in situ, and that 
population expansion in these cases is driven by proliferation rather than monocyte 
recruitment and differentiation23,30. Thus, in addition to blocking the expression of genes 
associated with M2 activation, inhibition of lipolysis may also effectively block IL-4-
induced macrophage proliferation, especially since fatty acids derived from the lipolysis of 
triacylglycerols can serve as building blocks for the synthesis of membrane lipids, which is 
critical in cells that are undergoing division. Lipolysis of triacylglycerols may also generate 
fatty acids that can serve as ligands for nuclear receptors such a PPARs, which regulate the 
expression of FAO genes and are critical for M2 activation40. It is feasible that inhibition of 
lipolysis influences macrophage fate following exposure to IL-4 by blocking these 
processes.
A recent report showed that IL-4 induces increased lipolysis in adipocytes by promoting 
HSL activity41. Nevertheless, we found that M2 activation associated with increased 
OXPHOS occurred normally in both ATGL-deficient and HSL-deficient (data not shown) 
macrophages, indicating that these cells use alternative pathways of lipolysis to liberate fatty 
acids from triacylglycerols. Our data show that this alternative pathway is mediated by the 
lysosomal lipase LAL, the expression of which we found to be increased in M2 
macrophages, and which has also been reported to be expressed more in human M2 than M1 
macrophages28. Interestingly, genes encoding lysosomal proteins are enriched by chromatin 
immunoprecipitation for STAT6 binding42, indicating that IL-4 generally induces lysosomal 
function. Our data provide strong support for the lysosomal lipolysis of triacylglycerols as 
being critical for optimal M2 activation, and implicate the uptake of triacylglycerol-carrying 
proteins such as VLDL and LDL through CD36 as playing a role in this process. 
Interestingly, we found that IL-4-induced increases in OXPHOS and expression of CD206, 
CD301, PD-L2 and RELMα were unaffected by deletion of Ldlr itself (data not shown). 
Recent reports have indicated that the uptake of oxidized LDL via CD36 and platelet-
activating factor receptor43, and the expression of the LDLR-related protein 1 (Lrp1)44 are 
sufficient to promote IL-4-independent expression of certain genes linked to the M2 
phenotype, although the mechanisms underlying these effects are unclear. Moreover, the 
neutral cholesterol esterase hydrolases Nceh1 and Ces1g have been implicated in the ability 
of macrophages to play an anti-inflammatory role in atherosclerosis45,46, and expression of 
both of these, as well as of Lrp1 was somewhat elevated after stimulation with IL-4.
Our findings suggest that in addition to fueling FAO through the lipolysis of exogenous 
triacylglycerols, M2 macrophages can utilize endogenous triacylglycerols, generated from 
de novo fatty acid synthesis, for the same purpose. We believe that these endogenously 
synthesized triacylglycerols contribute to lipid droplet formation in M2 cells in which 
lipolysis has been inhibited. On balance, the data indicate that the lipolysis of endogenously 
synthesized triacylglycerols is also mediated by LAL, since suppression of LAL expression 
in M2 cells also results in lipid droplet accumulation. It is unclear at present how LAL gains 
access to lipid droplets in M2 macrophages. In other nonadipocytes, lysosome-dependent 
autophagy has been reported to be important for the lipolysis of triacylglycerols in lipid 
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droplets38,47. We have not found evidence to support this pathway in M2 macrophages 
cultured in complete medium (data not shown), but it is feasible that autophagy programs 
are engaged when access to fatty acids from exogenous triacylglycerols is restricted. 
Regardless, autophagy-independent lysosomal lipolysis of lipid droplets by macrophages is 
not unprecedented48, so it remains feasible that the lipolysis of endogenously synthesized 
triacylglycerols occurs through novel mechanisms. These possibilities are under 
investigation.
M2 macrophages play important roles in immune responses to helminth parasites, acting to 
directly affect parasite health and persistence in sites of infection, and/or to regulate T cell 
responses and associated immunopathology. Using two models of immune elimination of 
the intestinal helminth parasite H. polygyrus, we found that inhibition of lipolysis 
significantly diminished anti-parasite immunity promoted by the injection of IL-4 into mice 
carrying a primary infection, and inhibited resistance to secondary infection in mice that 
were challenged following drug-cure of a primary infection. In both cases reductions in 
immunity were tightly correlated with reductions in OXPHOS and M2 marker expression in 
peritoneal macrophages. We found no evidence for an effect of inhibiting lipolysis on TH2 
cell responses, indicating that observed differences in immunity were unlikely to be linked 
to reductions in the production of type 2 effector cytokines by the adaptive response, 
although we have not formally ruled out an effect on other sources of IL-4 or IL-13. We 
infer from these findings that lipolysis plays a role in the M2 activation in vivo in the setting 
of helminth infections. There have been no reports of a role for LAL in immunity to 
parasitic helminths in mice or humans, but the latter may reflect the relative lack of GWAS 
to identify quantitative trait loci affecting human resistance to helminth parasites.
Collectively, our data indicate that macrophages utilize the lysosomal pathway to mobilize 
fatty acids to facilitate FAO and the M2 activation program. Our findings suggest that 
approaches for gain or loss of function of LAL may offer therapeutic potential in diseases 
where M2 macrophages play protective or detrimental effects.
Methods
Animals and in vivo experiments
C57BL/6J mice, 4get/KN2 mice, B6 Cd36–/– mice and B6.129P2-Pnpla2tm1Rze/J 
(Pnpla2–/–) mice were bred and maintained in specific pathogen free conditions under 
protocols approved by the institutional animal care committee at Washington University 
School of Medicine, and were used at 8-12 weeks of age. Lipa+/+ and Lipa–/– mice were 
maintained at Indiana State University under SPF conditions. In some experiments, mice 
were injected i.p. with tetrahydrolipistatin (Orlistat; 200 mg/kg, Cayman Chemical) or with 
300 μl of 3% thioglycollate (Sigma) immediately prior to IL-4 complexed to mAb anti-IL-4 
(IL-4c; containing 5 μg of IL-4, PeproTech, and 25 μg of anti-IL-4 clone 11B11, 
BioXcell)49. For infection with H. polygyrus bakeri, we followed protocols described in 
detail previously50. Mice were infected orally by gavage with 200 infective L3 stage larvae. 
For secondary infection experiments, adult H. polygyrus were eliminated from infected mice 
by oral administration of pyrantel pamoate (1 mg/mouse; Columbia Laboratory) at day 14 
post-primary infection, and > 5 weeks later the mice were challenge-infected with 200 L3 
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stage larvae by gavage. At day 9 post challenge infection, mice were sacrificed and parasite 
burdens were measured. To count worm, intestines were removed, opened longitudinally, 
and placed into a metal strainer on top of a 50 ml tube filled with phosphate buffered saline 
(PBS; Corning Inc.) for 4 h at 37 °C. Parasites dropped through the filter into the tube and 
were recovered for counting on a dissecting microscope. Parasite eggs were enumerated by 
floating eggs in feces collected from individual mice on saturated sodium chloride prior to 
collection, and counting under a microscope.
Isolation of cells from mice
Peritoneal exudate cells (PECs) were harvested from sacrificed naïve or infected mice by 
peritoneal lavage with 10 ml of sterile PBS containing 5% FBS (HyClone) per mouse. Total 
numbers of PECs and peritoneal macrophages were determined by cell counting in 
combination with multi-color flow cytometry. For analysis of lymphocyte activation by flow 
cytometry, single cell suspensions were prepared from lymphoid organs by forcing them 
through 70 μm strainers, and washing with RPMI containing 5% FBS (Corning Inc). Red 
blood cells were lysed with ACK lysis buffer (0.15 M NH4Cl, 1 mM KHCO3, 0.1 mM 
EDTA). Bone marrow was flushed from the femur and tibia using RPMI containing 5% FBS 
and dissociated into a single cell suspension by repeated pipetting. Cells were maintained on 
ice until use or analysis.
Preparation of macrophages from bone marrow and macrophage activation
Bone marrow cells were differentiated in the presence of recombinant mouse M-CSF (20 
ng/ml; R&D Systems) in complete medium (RPMI 1640 containing 10 mM glucose, 2 mM 
L-glutamine, 100 U/mL of penicillin/streptomycin and 10% FBS) for 7 days. Day 7 
macrophages were washed and variously stimulated with IL-4 (20 ng/ml; PeproTech) or 
lipopolysaccharide (LPS, 20 ng/ml; Sigma) plus IFN-γ (50 ng/ml; R&D Systems) in the 
presence or absence of 200 μM etomoxir (ETO; Sigma), 20 μM sulfo-n-succinimidyl oleate 
(SSO), 30 μM chloroquine (CLQ; Sigma), 0.1 μM bafilomycin A1 (Baf; Tocris Bioscience), 
100 μM Orlistat (Cayman), 20 μM 5-(Tetradecyloxy)-2-furoic Acid (TOFA, Sigma), 5 or 50 
μg/ml of LDL (Kalen Biomedical, LLC) and VLDL (Kalen Biomedical, LLC) for 24 h. 
Macrophages were then harvested and analyzed by flow cytometry for expression of 
markers of M1 or M2 activation. In some experiments the survival of macrophages was 
monitored following M2 or M1 activation. For these experiments, bone marrow-derived 
macrophages (0.5 × 106 cells per well of a 48-well plate) were cultured in complete medium 
with mouse M-CSF (20 ng/ml) and stimulated with IL-4 or LPS plus IFN-γ. Cell viability 
was monitored by flow cytometric analysis of 7-amino-actinomycin D (7-AAD; BioLegend) 
staining of F4/80+ cells over time. Culture medium and stimulation signals were replenished 
every 1 or 2 days.
Identification of human CD36-sufficient and -deficient subjects
Peripheral blood mononuclear cells (PBMC) were isolated from venous blood samples 
obtained from a CD36-deficient adult subject and an adult subject with normal CD36 
expression using Ficoll-Paque (GE Health Care) and density gradient centrifugation. The 
CD36-deficient subject is homozygous for the G allele (allele frequency ~10%) of coding 
SNP rs3111938 (T/G), which introduces a stop codon and results in a truncated protein that 
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is degraded. Homozygosity at the G allele results in complete CD36 deficiency51. The study 
was approved by the Washington University School of Medicine Institutional Review Board 
with written informed consent obtained from each subject.
Isolation of mononuclear cells from human peripheral blood and human macrophage 
activation
Monocytes were purified from PBMCs using human CD14 MicroBeads (MACS) and then 
differentiated into macrophages in complete RPMI medium containing 20 ng/ml 
recombinant human M-CSF (R&D Systems) for 8 days. Human macrophages were 
harvested on day 8, and stimulated with 20 ng/ml human IL-4 (R&D Systems) or 50 ng/ml 
human IFN-γ (R&D Systems) plus 20 ng/ml LPS for 24 h.
Retroviral transduction
Retroviral transduction of macrophages was accomplished using a protocol that we have 
used previously to transduce bone marrow derived dendritic cells52. Sequences for luciferase 
and for Lipa short hairpin RNAs (shRNAs) were obtained from Open Biosystems and 
cloned into the MSCV-LTRmir30-PI8 retroviral vector, encoding huCD8 as a reporter. Two 
independent sequences were used to target Lipa: TCAAGTCCAGCATTCACTG, and 
TGTGCTTCAGAGACCAGGT. Recombinant retroviruses were used for spin infection 
(800 x g, 2 h) of day 3 bone marrow macrophage cultures. After 7 days in culture with M-
CSF, macrophages were harvested and transduced macrophages were gated based on huCD8 
expression. Both shRNAs were used for experiments, with similar results, but only data 
from experiments that utilized TGTGCTTCAGAGACCAGGT are shown. For the bone 
marrow chimera, bone marrow cells from donor mice were collected and cultured in 
complete RPMI medium containing 10 ng/ml IL-3, 10 ng/ml IL-6 and 50 ng/ml murine c-kit 
ligand for 24 h. Cells were then transduced with retroviral shRNAs targeting Lipa or 
luciferase, and 5 × 105 transduced cells were intravenously injected into irradiated 
recipients. Recipients were used 6 – 10 weeks later.
Treatment of peritoneal macrophages with small interfering RNA (siRNA)
An siRNA targeting mouse LAL (Lipa; AAAGCUAUGAAACCAUGGTg) was purchased 
from Applied Biosystems, and Silencer Negative control siRNA#1, which is not matched to 
any sequence in the mouse genome, was also provided by the manufacturer and used as a 
control. siRNAs (50 nM) were complexed with Lipofectamine 2000 and delivered into 
peritoneal macrophages as per the manufacturer's instructions. siRNA-treated peritoneal 
macrophages were then stimulated with 20 ng/ml of IL-4 for 48 h prior to analysis.
Metabolism assays
For real-time analysis of extracellular acidification rates (ECAR) and oxygen consumption 
rates (OCR), macrophages were analyzed using an XF-96 Extracellular Flux Analyzer 
(EFA, Seahorse Bioscience) as described in detail for bone marrow-derived dendritic cells 
previously52. Three or more consecutive measurements were taken under basal conditions 
and following the sequential addition of 1 μM oligomycin to inhibit the mitochondrial ATP 
synthase, 1.5 μM fluoro-carbonyl cyanide phenylhydrazone (FCCP), a protonophore, which 
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uncouples ATP synthesis from oxygen consumption by the electron transport chain, and 100 
nM rotenone plus 1 μM antimycin A (Rot/Ant; all drugs for this assay were purchased from 
Sigma), which inhibit the electron transport chain. In this assay, basal oxygen consumption 
can be established by measuring OCR in the absence of drugs. Declines in OCR following 
the addition of oligomycin and rotenone and antimycin are expected and indicate that cells 
are consuming oxygen for mitochondrial OXPHOS. Spare respiratory capacity (SRC) is 
calculated as the difference between basal OCR and maximal OCR following the addition of 
FCCP. Maximal OCR occurs following the addition of FCCP since cells attempt to maintain 
a proton gradient across the inner mitochondrial membrane by increasing the consumption 
of oxygen by the electron transport chain10,53. Global metabolite profiling of stimulated 
macrophages was performed using mass spectrometry by Metabolon, Durham, NC. Glycerol 
in macrophage supernatants was measured using absorbance at 570 nm after incubation with 
Free Glycerol Reagent (Sigma) and by comparison to a glycerol standard (Sigma). For the 
lipidomic analysis, washed cell pellets were frozen and thawed and homogenized in 500 μl 
of PBS using an Omni Bead Ruptor 24 (Omni International, Inc.). 50 μl of each homogenate 
was reserved for protein measurement. 450 μl of each homogenate was used for lipidomic 
analysis. A modified Bligh-Dyer extraction method was used to extract lipids in the 
presence of an internal standard mixture. Mass spectrometric measurement was performed 
with a Shimadzu 10A HPLC system coupled to a TSQ Quantum Ultra triple quadrupole 
mass spectrometer operated in SRM mode under ESI(+). Different analytical HPLC 
columns and mobile phases were employed for different analytes to achieve the optimal 
sensitivity and separation. A pooled lipid extract from study samples was used as a quality 
control (QC), and was injected between every sample to verify the instrumental consistency, 
which is described as %CV of QC. Only the species with (%CV of QC) < 15% were 
reported. Data processing was conducted with Xcalibur software (Thermo). The 
concentration of an analyte was calculated as the concentration of its corresponding internal 
standard multiplied by the peak area ratio of the analyte to the internal standard, based on 
the assumption that the MS responses of the analyte and internal standard are the same.
Flow Cytometry
Cells were kept at 4 °C and blocked with 5 μg/ml of anti-CD16/32 (clone 93, eBiosciences) 
before surface staining with antibodies to CD11b (clone M1/70, eBiosciences), F4/80 (clone 
BM8, eBiosciences), CD206 (clone C068C2, Biolegend), CD301 (clone ER-MP23, AbD 
Serotec), PD-L2 (clone TY25, eBiosciences), CD62L (clone MEL-14, BD Biosciences), 
CD44 (clone IM7, BD Biosciences), CD4 (clone RM4-5, BD Biosciences), and/or human 
CD2 (clone RPA-2.10, BD Biosciences). For intracellular staining of RELMα and iNOS, 
cells were fixed in 4% ultrapure paraformaldehyde, and stained with rabbit anti-RELMα 
(PeproTech) and mouse anti-Nos2 (clone C-11; Santa Cruz Biotechnology) for 1 h at 22°C 
in 0.2% saponin buffer, followed by incubation with appropriate fluorochrome-conjugated 
anti-rabbit or anti-mouse IgG (both Jackson Immunoresearch) in the same buffer. BODIPY 
labeled LDL (10 μg/ml, Invitrogen), BODIPY labeled VLDL (10 μg/ml, Kalen Biomedical, 
LLC) and BODIPY labeled palmitate (1 μM, Invitrogen) were used in conjunction with flow 
cytometry for uptake experiments. Intracellular neutral lipids were stained with 500 ng/ml 
BODIPY 493/503 (Invitrogen) and measured by flow cytometry. All macrophage staining 
data shown represent cells that were gated as CD11b+F4/80+, and living based on staining 
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with LIVE/DEAD (Invitrogen) or 7-amino-actinomycin D (eBiosciences). Human 
macrophages were stained with antibodies to human CD14 (clone MφPg, BD Biosciences), 
human CD36 (clone CB38, BD Biosciences) and human CD206 (clone 15-2, Biolegend). 
Staining results are shown for CD14+ cells. Data were acquired on a FACSCanto II flow 
cytometer (BD Biosciences), and analyzed with FlowJo v.9.5.2 (Tree Star Inc.).
RNA-sequencing
mRNA was extracted from lysates of cells that had been stimulated for 24 h, using oligodT 
beads (Invitrogen). cDNA synthesis, sequencing and sequence analysis were performed as 
described53. Raw and processed sequencing data were deposited to Pubmed.
Transmission electron microscopy
For ultrastructural analysis, cells were fixed in 2% paraformaldehyde, 2.5% glutaraldehyde 
(Polysciences Inc.), 0.05% malachite green (Sigma) in 100 mM sodium cacodylate buffer, 
pH 7.2 for 1 h at 22°C. The malachite green was incorporated into the fixative to stabilize 
lipid constituents soluble in aqueous glutaraldehyde. Samples were washed in cacodylate 
buffer and post-fixed in 1% osmium tetroxide (Polysciences Inc.) for 1 h. Samples were then 
rinsed extensively in distilled H2O prior to en bloc staining with 1% aqueous uranyl acetate 
(Ted Pella Inc.) for 1 h. Following several rinses in dH2O, samples were dehydrated in a 
graded series of ethanol and embedded in Eponate 12 resin (Ted Pella Inc.). Sections of 95 
nm were cut with a Leica Ultracut UC7 ultramicrotome (Leica Microsystems Inc.), stained 
with uranyl acetate and lead citrate, and viewed on a JEOL 1200 EX transmission electron 
microscope (JEOL USA Inc.) equipped with an AMT 8 megapixel digital camera 
(Advanced Microscopy Techniques).
Statistical analysis
Data were analyzed using Graphpad Prism (v5). Comparisons for two groups were 
calculated using One-way ANOVA and, where indicated, unpaired two-tailed Student's t-
tests. Differences were considered significant when P-values were below 0.05. No 
randomization or exclusion of data points was used. Pilot in vivo studies were used for 
estimation of the sample size required to ensure adequate power.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
M2 activation is marked by increased spare respiratory capacity and is dependent on fatty 
acid oxidation. (a) Bone marrow-derived macrophages were cultured in medium without 
(M0) or with IFN-γ + LPS (M1), or with IL-4 (M2) for 24 h and then oxygen consumption 
rates (OCR) was determined using an XF-96 Extracellular Flux Analyzer (EFA) during 
sequential treatments with oligomycin, FCCP, and rotenone/antimycin. Spare respiratory 
capacity (SRC), the quantitative difference between maximal uncontrolled OCR, and the 
initial basal OCR, is depicted in the plot. (b) M1 and M2 macrophage basal extracellular 
acidification rates (ECAR, changes in mpH per unit time), measured in real time using the 
EFA. (c) Ratios of OCR/ECAR for M1 and M2 macrophages. (d) The effect of etomoxir 
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(ETO) on basal OCR in M2 macrophages. Basal OCR for M0 macrophages is shown as a 
reference. (e) The effect of ETO on M2 SRC as defined in (a). (f) The effect of ETO on 
CD206 and CD301 expression by M2 macrophages, as measured by flow cytometry. 
Expression on M0 macrophages is shown for reference. (g) Effect of ETO on 
RELMαexpression by M2 macrophages. (h) Effect of ETO on iNOS expression by M1 
macrophages. In these experiments ETO was included in the culture from the time at which 
M2 or M1 polarizing conditions were initiated, and data were collected 24 h later. Data in a-
e are means + SEM (a) or ± SEM of 5 or more technical replicates from one experiment, and 
are representative of more than three independent experiments.. In f, numbers represent % of 
macrophages falling within indicated gates; plots shown are from one representative 
experiment of 2, but numbers are mean ± SEM of data from both experiments. . In g 
histograms show plots from one experiment representative of 3, and the bar graph shows 
mean relative geometric mean fluorescence intensity (gMFI) values ± SEM from 3 
independent experiments. In h, histograms show plots from one experiment representative of 
2. The mean % of cells that were iNOS positive in these two experiments were 69.7% ± 
1.3% (SEM) for M1 cells and 60.5% ± 9.7% for M1 plus ETO. P-values are from Student's 
t-test (*P < 0.05, **P < 0.0001).
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Figure. 2. 
Lipolysis is essential for M2 activation and survival. (a) Abundance of the 
monoacylglycerols 1-oleoylglycerol, 1-palmitoylglycerol, 1stearoglycerol and 2-
palmitoylglycerol in extracts of M2 compared to M1 macrophages were assessed by mass 
spectrometry (AU, arbitrary units). (b) Glycerol concentrations in 24 h culture supernatants 
of M0 macrophages, M2 macrophages, and M2 macrophages treated with the lipase 
inhibitor tetrahydrolipistatin (Orlistat, 100 μM). (c-g) The effect of inhibiting lipolysis with 
Orlistat on (c) basal OCR and SRC in M2 macrophages, (d) basal OCR, and on the basal 
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OCR/ ECAR ratio in M1 macrophages, (e) M2 macrophage survival, (f) CD206, CD301, 
PD-L2 and RELMα expression by M2 macrophages, as measured by flow cytometry, (g) 
iNOS expression in M1 macrophages. In these experiments Orlistat was included in the 
culture from the time at which M2 or M1 polarizing conditions were initiated and data were 
collected 24 h (a-d, f, g) or 48 h (e) later. Data for M0 macrophages are shown in c,d,f, and 
g for reference. Data in a show means ± SEM from 4 independent experiments. Data in b-e 
are means ± SEM of 3 technical replicates from one experiment representative of 3. In f, 
numbers represent % of macrophages falling within indicated gates; plots shown are from 
one representative experiment of 2, but numbers are mean ± SEM of data from both 
experiments. In g histograms show plots from one experiment representative of 2. The mean 
% of cells that were iNOS positive in these two experiments were 68.2 ± 5.0% (SEM) for 
M1 cells and 70.2% ± 6.7% for M1 plus Orlistat. data are P values are from Student's t-test 
(*P < 0.05; **P < 0.01; ***P < 0.0001).
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Figure 3. 
Lipolysis for M2 activation is mediated by lysosomal acid lipase. (a) RNA-Seq analysis of 
the relative expression in M2 and M1 macrophages of genes involved in lipolysis. (b) 
Transmission electron micrographs of bone marrow derived M1 and M2 macrophages. Blue 
arrowheads indicate mitochondria, yellow asterixes indicate lysosomes, and red arrowheads 
indicate lipid droplets. Graph shows numbers of lipid droplets (LD) per cell in M1 and M2 
cells (150 cells per condition were examined, and data represent means ± SEM). (c) The 
effect of neutralizing lysosomal pH with chloroquine (CLQ) or Bafilomycin (Baf) on basal 
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OCR, the ratio of OCR/ECAR, and SRC in M2 macrophages. Basal OCR and OCR/ECAR 
ratios for M0 macrophages are shown as a reference. (d) The effect of CLQ and Baf on 
CD206, CD301, PD-L2 and RELMα expression by M2 macrophages, as measured by flow 
cytometry. Expression for M0 macrophages is shown for reference. (e) Effects on M2 cell 
viability of culturing for 24 h in CLQ or Baf. (f) Basal OCR, relative to M0 macrophages, of 
M2 macrophages transduced with either control virus (Luc shRNA) or virus expressing 
shRNA against Lipa (Lipa shRNA). (g,h) Expression of CD206 and CD301 and of PD-L2 
and of RELMα (g) and cellular viability (h) of macrophages transduced with Luc shRNA or 
Lipa shRNA prior to culture in M0 or M2 conditions. For (h), cells were cultured for 2 days 
before assessment. (i) Expression of CD206, CD301 and RELMα by wild-type (Lipa+/+) or 
Lipa-/-M0 or M2 macrophages. (j) %RELMα positive Lipa shRNA transduced vs Luc 
shRNA transduced huCD8+ peritoneal macrophages from bone marrow chimeric mice 
injected with PBS or IL-4c (left). Data from untransduced huCD8- peritoneal macrophages 
from the same mice are shown for comparison (right). Data in a are from 2 separate 
experiments. Images in b are from individual cells, representative of over 150 examined 
from 2 independent experiments. Data in the graph are mean ± SEM values of numbers of 
typical lipid droplets (LD) per cell, from 2 independent experiments Data in c, e and f are 
means ± SEM of 3 technical replicates from one experiment representative of 3. In d, g, and 
i, numbers represent % of macrophages falling within indicated gates; plots shown are from 
one representative experiment of 2, but numbers are mean ± SEM of data from both 
experiments. Data in bar graphs in h and i are of mean ± SEM values from 2-3 independent 
experiments. Data in j are from mean ± SEM values from a minimum of 2 independent 
mice. P values are from Student’s t-test (*P < 0.05; **P < 0.01; ***P < 0.0001).
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Figure 4. 
CD36 is critical for M2 activation. (a) RNA-Seq analysis of the relative expression in M2 
vs. M1 macrophages of genes involved in the uptake of triacylglycerol-carrying proteins. (b, 
c) The uptake of BODIPY labeled LDL (a) and VLDL (b) by M0 and M2 WT (Cd36+/+) 
and Cd36-/- macrophages, as measured by flow cytometry. Top panels show histograms 
from one experiment, bottom panels show gMFI from duplicate experiments. Fluoresence 
staining was compared to unstained cells (US). (d) basal OCR, the ratio of basal OCR to 
basal ECAR, and SRC in M2 WT and Cd36-/- M2 macrophages, (e) basal OCR and the ratio 
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of basal OCR to basal ECAR in WT and Cd36-/- M1 macrophages, (f) PD-L2 and RELMα 
expression by WT and Cd36-/- M2 macrophages, (g) iNOS expression by WT and Cd36-/- 
M1 macrophages. Data in b-g from M0 macrophages are shown for comparison. (h) OCR 
readings, in real time, for human control and CD36-deficient M0 and M2 macrophages 
(derived from monocytes that were cultured in M-CSF for 8 days prior to treatment with 
cytokine), at basal and following sequential treatments with oligomycin, FCCP, and 
rotenone/antimycin A. Data have been baselined relative to each other. (i) Expression of 
CD36 and CD206 in control and CD36 deficient human M0, M1 and M2 monocyte-derived 
macrophages. Data in a are from 2 separate experiments. In b-c data in histograms are from 
one experiment representative of 2, and data in bar graphs represent mean ± SEM values 
from 2 independent experiments. In d and e data are means ± SEM of 3 technical replicates 
from one experiment representative of 2 independent experiments. Numbers in f and g 
represent % of macrophages falling within the indicated gates. In f, plots are from 1 
experiment representative of 2, but numbers represent mean ± SEM values from 2 
independent experiments. In g graphs are from one experiment representative of 2, but 
numbers represent mean ± SEM values from 2 independent experiments. In h data are mean 
+ SEM values from a minimum of 4 technical replicates from cells from one subject. P 
values are from Student's t-test (*P < 0.01; **P < 0.0001).
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Figure 5. 
The peritoneal cavity is a site of M2 macrophage activation during infection with H. 
polygrus, and M2 macrophage activation is LAL-dependent. (a) Total numbers of 
CD11b+F4/80+ peritoneal macrophages in naïve mice and in infected mice at various days 
post-infection with H. polygyrus. (b) OCR readings, in real time, for macrophages from 
uninfected (Naïve) or infected mice (day 9) at basal and following sequential treatments 
with oligomycin, FCCP, and rotenone/antimycin A. SRC is depicted in the plot. (c) RELMα 
expression in peritoneal macrophages from naïve mice and from mice infected with H. 
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polygyrus for 9 days. The graph to the right shows the % of all peritoneal cells that are 
RELMα+ macrophages. (d,f) Baseline OCR of ex vivo peritoneal macrophages from naïve 
mice, or from infected mice following treatment with control (siCtrl) or Lipa (siLipa) 
siRNAs and culture for 12 h in the absence (d) or presence (f) of added IL-4. (e,g) RELMα 
expression by the macrophage populations described in d and f. In a data are means ± SEM 
for cells taken from 2 - 4 individual mice from one experiment representative of 3. In b, data 
are mean + SEM values for 5 technical replicates for cells from 2 – 4 mice per group from 1 
experiment representative of 3. In c the histogram shows data from cells pooled from 2 
individual mice and the bar graph shows mean ± SEM values from 2 – 3 individual mice per 
group from 1 experiment representative of 3. In d, and f, bar graphs show mean ± SEM 
values for 3 technical replicates for cells pooled from 2 mice per group from 1 experiment 
representative of 2. In e data in histograms are from 1 mouse, representative of 2 mice per 
group, representative of 2 experiments. In g, data are mean ± SEM values for data from 2 
mice per group from one experiment representative of 2. P values are from Student's t-test 
(*P < 0.05; **P < 0.0001).
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Figure 6. 
Inhibition of lipolysis suppresses IL-4 driven M2 macrophage activation in vivo and the 
elimination of a primary H. polygyrus infection. Mice were infected and at day 9 groups of 
infected mice were injected with PBS (Ctrl), IL-4c, or IL-4c plus Orlistat. IL-4c injections 
were repeated on day 14 post infection. Orlistat treatment was repeated on days 11, 14 and 
16 post infection. The experiment was terminated at day 17 after infection. (a) Basal OCR 
readings of peritoneal macrophages isolated from naïve mice, and from infected mice treated 
as shown. (b) RELMα expression by peritoneal macrophages from the various treatment 
groups. Left panel shows mean fluorescence intensity (MFI) and right panel shows % of 
macrophages staining positive for RELMα. (c) Fecal egg counts over time in mice treated as 
indicated. (d) Adult worm counts at day 17 in mice treated as indicated. In a, data are means 
± SEM from 5 technical replicates of cells from 3 – 6 mice per group from one experiment 
representative of 2. In b (bar graphs) c and d, data are means ± SEM from 3 - 6 mice per 
group from one experiment representative of 2. In b, the histograms are from cells from one 
mouse per group, representative of 3 – 6 mice per group from one experiment representative 
of 2. P values are from Student's t-test, NS = not significant. Data are from individual 
experiments representative of two independent experiments. (*P < 0.05; **P < 0.0001)
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Figure. 7. Inhibition of lipolysis suppresses resistance to reinfection with H.polygyrus
Mice were infected with H. polygyrus and treated with the anti-helminthic pyrantel pamoate 
prior to receiving a secondary infection (2°Hp). At the time of secondary infection, 
additional groups of mice were infected for the first time to provide primary H. polygyrus 
infection controls (1°Hp). Infected mice were treated (or not) with Orlistat on the day of 
infection and on days 2, 4, 6 and 8 post infection. The experiment was terminated on day 9 
post 1° or 2° infection. (a) Numbers of CD11b+F4/80+ peritoneal macrophages in mice 
treated as indicated.(b) Basal OCR readings of peritoneal macrophages isolated from mice 
treated as indicated. (c) RELMα expression by peritoneal macrophages from the various 
treatment groups. Left panel shows mean fluorescence intensity (MFI) and right panel shows 
% of macrophages staining positive for RELMα. (d) Adult worm counts in mice treated as 
indicated. In a, c,(bar graph) and d, data are means ± SEM from 4 – 10 independently 
assessed mice per group from 1 experiment representative of 2. In b, data represent mean + 
SEM values for 5 technical replicates from cells from 4 – 8 or more mice per group from 
one experiment representative of 2. In c, data in the histogram are from 1 mouse 
representative of 3 – 8 mice per group from 1 experiment representative of 2. The numbers 
in the key are MFI values. In d data are from 5 – 8 individually assessed mice per 
experimental group. Data are from individual experiments representative of two independent 
experiments. P values are from Student's t-test, NS = not significant (*P < 0.05; **P < 
0.0001).
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